Patents by Inventor Winship Herr

Winship Herr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050164210
    Abstract: The invention provides, among other things, regulated polymerase III expression systems and related compositions. The invention provides, in part, expression systems in which the expression is inducible, and systems which express inhibitory RNA molecules, such as hairpin RNA molecules. The invention also provides related methods, such as methods of inhibiting expression of a gene.
    Type: Application
    Filed: January 23, 2004
    Publication date: July 28, 2005
    Inventors: Vivek Mittal, Sunita Gupta, Gregory Hannon, Patrick Paddison, Eric Julien, Winship Herr
  • Patent number: 5585239
    Abstract: Host Cell Factor (HCF), a eukaryotic cellular protein involved in transcription, nucleic acids encoding HCF, and methods of using HCF and HCF-encoding nucleic acids are provided. HCF activity is disclosed to comprise a collection of polypeptides encoded by a structural gene encoding a parent protein of 2039 amino acids. HCF-specific binding compounds are disclosed including antibodies to HCF epitopes. Because HCF is required for the transcription of a number of viral genes such as the immediate early genes of Herpes Simplex Virus, the invention provides HCF-based pharmaceutical compositions and HCF-based methods for screening chemical libraries for regulators of viral transcription. Such compositions are used in the treatment of viral infections by modulating the transcription of certain viral genes.
    Type: Grant
    Filed: February 24, 1995
    Date of Patent: December 17, 1996
    Assignee: Tularik, Inc.
    Inventors: Kelly Lamarco, Angus Wilson, Winship Herr
  • Patent number: 5453362
    Abstract: Host Cell Factor (HCF), a eukaryotic cellular protein involved in transcription, nucleic acids encoding HCF, and methods of using HCF and HCF-encoding nucleic acids are provided. HCF activity is disclosed to comprise a collection of polypeptides encoded by a structural gene encoding a parent protein of 2039 amino acids. HCF-specific binding compounds are disclose including antibodies to HCF epitopes. Because HCF is required for the transcription of a number of vital genes such as the immediate early genes of Herpes Simplex Virus, the invention provides HCF-based methods for screening chemical libraries for regulators of viral transcription. Such regulators are used in the treatment of viral infections by modulating the transcription of certain viral genes.
    Type: Grant
    Filed: April 12, 1993
    Date of Patent: September 26, 1995
    Assignees: Tularik Inc., Cold Spring Harbor Laboratory
    Inventors: Kelly Lamarco, Angus Wilson, Winship Herr